Blood cancers, Cell type, Hodgkin lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)
Results
Phase 2
This trial was for people whose lymphoma got worse during treatment or came back afterwards. People who had had a or weren’t fit enough to have one could take part.
The trial was open for people to join between 2015 and 2017. The team published the results in 2019.
Recruitment start: 19 October 2015
Recruitment end: 25 April 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Graham Collins
AstraZeneca
Bloodwise
NIHR Clinical Research Network: Cancer
University of Birmingham
Last reviewed: 11 February 2021
CRUK internal database number: 12249
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
